Maged Shenouda, CFO at RELMADA THERAPEUTICS, INC. (RLMD), sold 3,200 shares at $35.04 ($112K) on 2021-02-02, disclosed to the SEC on 2021-02-04.
Open-market sale of $112k RLMD by CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.04 | 3,100 | $109K | 96.9% |
| 2 | $35.00 | 100 | $4K | 3.1% |
| Total | $35.04 avg | 3,200 | $112K | 100% |
| Filing → |
| RLMD | BUY | 2025-11-06 | $1.1M | — | Filing → |
| RLMD | BUY | 2025-05-20 | $97K | — | Filing → |
| RLMD | BUY | 2024-09-11 | $207K | — | Filing → |